Insider Transactions in Q4 2024 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2024
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
10,308
-2.11%
|
$546,324
$53.5 P/Share
|
|
Dec 03
2024
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,308
+3.29%
|
$340,164
$33.02 P/Share
|
|
Dec 02
2024
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
85,600
-24.8%
|
$4,451,200
$52.21 P/Share
|
|
Dec 02
2024
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
85,600
+17.12%
|
$4,365,600
$51.0 P/Share
|
|
Dec 02
2024
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
17,800
-7.19%
|
$907,800
$51.89 P/Share
|
|
Dec 02
2024
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
17,800
+11.63%
|
$907,800
$51.0 P/Share
|
|
Dec 02
2024
|
Jerome B Zeldis |
SELL
Open market or private sale
|
Direct |
24,000
-21.13%
|
$1,224,000
$51.64 P/Share
|
|
Dec 02
2024
|
Jerome B Zeldis |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+31.17%
|
$960,000
$40.93 P/Share
|
|
Dec 02
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
2,060
-16.29%
|
$107,120
$52.3 P/Share
|
|
Dec 02
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,060
+23.69%
|
$105,060
$51.0 P/Share
|
|
Dec 02
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
69,550
-12.53%
|
$3,616,600
$52.32 P/Share
|
|
Dec 02
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
69,550
+16.63%
|
$3,547,050
$51.0 P/Share
|